 Mayra Maymone
Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dermatology | 18 | 2024 | 130 | 4.180 |
Why?
| | Beauty | 8 | 2023 | 19 | 2.720 |
Why?
| | Hyperpigmentation | 8 | 2021 | 27 | 2.590 |
Why?
| | Skin Diseases | 8 | 2022 | 152 | 1.790 |
Why?
| | Body Dysmorphic Disorders | 5 | 2023 | 11 | 1.760 |
Why?
| | Social Media | 5 | 2023 | 166 | 1.490 |
Why?
| | Sunscreening Agents | 5 | 2022 | 25 | 1.450 |
Why?
| | Cosmetic Techniques | 8 | 2023 | 18 | 1.300 |
Why?
| | Melanosis | 4 | 2024 | 16 | 1.280 |
Why?
| | Leprosy | 2 | 2020 | 25 | 1.240 |
Why?
| | Skin | 9 | 2022 | 753 | 1.120 |
Why?
| | Mouth Mucosa | 2 | 2018 | 85 | 1.110 |
Why?
| | Skin Pigmentation | 5 | 2022 | 48 | 1.090 |
Why?
| | Chemexfoliation | 2 | 2024 | 2 | 0.970 |
Why?
| | Authorship | 4 | 2024 | 49 | 0.970 |
Why?
| | Bibliometrics | 5 | 2022 | 66 | 0.970 |
Why?
| | Body Image | 5 | 2023 | 96 | 0.960 |
Why?
| | Croton Oil | 1 | 2024 | 3 | 0.840 |
Why?
| | Publishing | 4 | 2024 | 114 | 0.770 |
Why?
| | Face | 4 | 2019 | 174 | 0.760 |
Why?
| | Esthetics | 5 | 2023 | 50 | 0.690 |
Why?
| | Facial Dermatoses | 2 | 2019 | 17 | 0.620 |
Why?
| | Sunburn | 1 | 2019 | 26 | 0.600 |
Why?
| | Rhinoplasty | 1 | 2019 | 39 | 0.560 |
Why?
| | Quality of Life | 6 | 2021 | 3204 | 0.560 |
Why?
| | Mouth | 1 | 2018 | 86 | 0.550 |
Why?
| | Foreign-Body Reaction | 1 | 2018 | 34 | 0.550 |
Why?
| | Mouth Neoplasms | 1 | 2018 | 90 | 0.530 |
Why?
| | Communication Barriers | 1 | 2019 | 130 | 0.530 |
Why?
| | Color Perception | 1 | 2017 | 25 | 0.530 |
Why?
| | Environment, Controlled | 1 | 2017 | 22 | 0.530 |
Why?
| | Sickness Impact Profile | 1 | 2017 | 62 | 0.520 |
Why?
| | Sunlight | 2 | 2019 | 78 | 0.510 |
Why?
| | Object Attachment | 1 | 2017 | 48 | 0.510 |
Why?
| | Facial Recognition | 1 | 2017 | 35 | 0.500 |
Why?
| | Precancerous Conditions | 1 | 2018 | 166 | 0.500 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 337 | 0.480 |
Why?
| | Mobile Applications | 1 | 2019 | 199 | 0.470 |
Why?
| | Perception | 1 | 2019 | 378 | 0.470 |
Why?
| | Humans | 62 | 2024 | 145474 | 0.470 |
Why?
| | Outpatients | 1 | 2019 | 447 | 0.460 |
Why?
| | Light | 2 | 2022 | 403 | 0.460 |
Why?
| | Photography | 4 | 2021 | 119 | 0.450 |
Why?
| | Affect | 1 | 2017 | 320 | 0.420 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2020 | 1419 | 0.420 |
Why?
| | Psychiatry | 1 | 2017 | 194 | 0.420 |
Why?
| | Early Detection of Cancer | 1 | 2018 | 485 | 0.390 |
Why?
| | Cross-Sectional Studies | 10 | 2024 | 5904 | 0.390 |
Why?
| | Delivery of Health Care | 2 | 2021 | 946 | 0.380 |
Why?
| | Research Design | 1 | 2018 | 1137 | 0.350 |
Why?
| | Biomedical Research | 1 | 2018 | 717 | 0.340 |
Why?
| | Surveys and Questionnaires | 6 | 2023 | 6066 | 0.340 |
Why?
| | Health Behavior | 1 | 2017 | 789 | 0.330 |
Why?
| | Dermatologists | 2 | 2021 | 7 | 0.320 |
Why?
| | Education, Medical, Continuing | 4 | 2018 | 133 | 0.320 |
Why?
| | Diagnosis, Differential | 3 | 2020 | 1508 | 0.320 |
Why?
| | Female | 26 | 2024 | 78844 | 0.320 |
Why?
| | Skin Neoplasms | 4 | 2021 | 849 | 0.310 |
Why?
| | Adult | 15 | 2024 | 40777 | 0.300 |
Why?
| | Male | 25 | 2024 | 72842 | 0.300 |
Why?
| | Biopsy, Needle | 2 | 2018 | 185 | 0.270 |
Why?
| | Dermal Fillers | 3 | 2022 | 3 | 0.270 |
Why?
| | Middle Aged | 13 | 2024 | 36215 | 0.240 |
Why?
| | Risk Assessment | 4 | 2018 | 3747 | 0.220 |
Why?
| | Time Factors | 3 | 2024 | 7123 | 0.220 |
Why?
| | Patient Satisfaction | 2 | 2019 | 709 | 0.210 |
Why?
| | Immunohistochemistry | 2 | 2018 | 1716 | 0.210 |
Why?
| | Croton | 1 | 2024 | 1 | 0.210 |
Why?
| | Phenol | 1 | 2024 | 15 | 0.210 |
Why?
| | Young Adult | 7 | 2020 | 14218 | 0.200 |
Why?
| | Sex Factors | 3 | 2020 | 2105 | 0.190 |
Why?
| | Periodicals as Topic | 3 | 2024 | 209 | 0.190 |
Why?
| | Raynaud Disease | 1 | 2022 | 3 | 0.180 |
Why?
| | History, 20th Century | 3 | 2019 | 328 | 0.180 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1581 | 0.180 |
Why?
| | Myofibromatosis | 1 | 2021 | 10 | 0.180 |
Why?
| | Endocarditis, Bacterial | 1 | 2022 | 46 | 0.170 |
Why?
| | Direct-to-Consumer Advertising | 1 | 2021 | 8 | 0.170 |
Why?
| | Comprehension | 2 | 2020 | 186 | 0.170 |
Why?
| | Cultural Characteristics | 2 | 2018 | 69 | 0.170 |
Why?
| | Peripheral Vascular Diseases | 1 | 2022 | 104 | 0.170 |
Why?
| | Keratinocytes | 2 | 2019 | 249 | 0.170 |
Why?
| | Sunbathing | 1 | 2021 | 16 | 0.170 |
Why?
| | Laser Therapy | 1 | 2023 | 144 | 0.170 |
Why?
| | Age Factors | 2 | 2019 | 3342 | 0.160 |
Why?
| | Incidence | 4 | 2020 | 2923 | 0.160 |
Why?
| | Subcutaneous Tissue | 1 | 2020 | 26 | 0.160 |
Why?
| | Lupus Erythematosus, Discoid | 1 | 2020 | 5 | 0.160 |
Why?
| | Scleroderma, Localized | 1 | 2020 | 11 | 0.160 |
Why?
| | Waist-Hip Ratio | 1 | 2020 | 37 | 0.160 |
Why?
| | Endemic Diseases | 1 | 2020 | 33 | 0.160 |
Why?
| | Body Fat Distribution | 1 | 2020 | 46 | 0.150 |
Why?
| | Knowledge | 1 | 2020 | 57 | 0.150 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2022 | 531 | 0.150 |
Why?
| | Acne Vulgaris | 1 | 2020 | 25 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2024 | 2028 | 0.150 |
Why?
| | Global Health | 2 | 2020 | 403 | 0.150 |
Why?
| | Skin Care | 1 | 2019 | 22 | 0.150 |
Why?
| | Genitalia | 1 | 2019 | 33 | 0.150 |
Why?
| | Fees and Charges | 1 | 2019 | 12 | 0.150 |
Why?
| | Skin Aging | 1 | 2019 | 21 | 0.150 |
Why?
| | Cicatrix | 1 | 2020 | 69 | 0.150 |
Why?
| | Internationality | 1 | 2020 | 156 | 0.150 |
Why?
| | Prevalence | 3 | 2023 | 2865 | 0.150 |
Why?
| | Scleroderma, Systemic | 1 | 2020 | 123 | 0.150 |
Why?
| | Skin Diseases, Papulosquamous | 1 | 2019 | 2 | 0.150 |
Why?
| | Ultraviolet Rays | 2 | 2022 | 384 | 0.150 |
Why?
| | Skin Diseases, Genetic | 1 | 2019 | 13 | 0.150 |
Why?
| | Culture | 1 | 2020 | 124 | 0.150 |
Why?
| | Dermatologic Agents | 1 | 2019 | 68 | 0.140 |
Why?
| | Social Networking | 1 | 2019 | 32 | 0.140 |
Why?
| | Adolescent | 7 | 2021 | 22529 | 0.140 |
Why?
| | Community Pharmacy Services | 1 | 2019 | 46 | 0.140 |
Why?
| | Videoconferencing | 1 | 2019 | 65 | 0.140 |
Why?
| | Drug Resistance, Bacterial | 1 | 2020 | 185 | 0.140 |
Why?
| | Medicine, Chinese Traditional | 1 | 2018 | 8 | 0.140 |
Why?
| | Psychology, Adolescent | 1 | 2018 | 61 | 0.140 |
Why?
| | Mouth Diseases | 1 | 2018 | 47 | 0.140 |
Why?
| | Habits | 1 | 2018 | 52 | 0.140 |
Why?
| | China | 1 | 2019 | 270 | 0.140 |
Why?
| | Physician-Patient Relations | 2 | 2021 | 588 | 0.140 |
Why?
| | Acupuncture Therapy | 1 | 2018 | 21 | 0.140 |
Why?
| | Erythema | 1 | 2018 | 28 | 0.140 |
Why?
| | Databases, Factual | 2 | 2021 | 1490 | 0.140 |
Why?
| | Patients | 1 | 2019 | 183 | 0.130 |
Why?
| | Physical Examination | 1 | 2019 | 243 | 0.130 |
Why?
| | Cell Phone | 1 | 2018 | 82 | 0.130 |
Why?
| | Peer Review | 1 | 2018 | 47 | 0.130 |
Why?
| | Peer Review, Research | 1 | 2018 | 36 | 0.130 |
Why?
| | History, 19th Century | 1 | 2017 | 63 | 0.130 |
Why?
| | Cost of Illness | 1 | 2020 | 324 | 0.130 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2018 | 73 | 0.130 |
Why?
| | Sun Protection Factor | 1 | 2017 | 1 | 0.130 |
Why?
| | Language | 1 | 2020 | 323 | 0.130 |
Why?
| | Treatment Outcome | 5 | 2024 | 11772 | 0.130 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 1044 | 0.130 |
Why?
| | Health Status Disparities | 1 | 2020 | 321 | 0.120 |
Why?
| | Melanoma | 2 | 2020 | 759 | 0.120 |
Why?
| | Recurrence | 1 | 2020 | 1138 | 0.120 |
Why?
| | Writing | 1 | 2018 | 101 | 0.120 |
Why?
| | Guidelines as Topic | 1 | 2018 | 266 | 0.120 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2020 | 440 | 0.110 |
Why?
| | Diagnostic Imaging | 1 | 2018 | 337 | 0.110 |
Why?
| | Motivation | 1 | 2019 | 600 | 0.110 |
Why?
| | Patient Acceptance of Health Care | 1 | 2021 | 881 | 0.110 |
Why?
| | Sex Characteristics | 1 | 2019 | 782 | 0.100 |
Why?
| | Internet | 1 | 2018 | 689 | 0.100 |
Why?
| | Patient Education as Topic | 1 | 2018 | 777 | 0.100 |
Why?
| | Health Personnel | 1 | 2019 | 754 | 0.090 |
Why?
| | Risk Factors | 3 | 2020 | 10885 | 0.080 |
Why?
| | Professional Practice Gaps | 2 | 2020 | 15 | 0.080 |
Why?
| | Aged | 6 | 2020 | 26153 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2187 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 1923 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5423 | 0.070 |
Why?
| | Pregnancy | 1 | 2020 | 7202 | 0.060 |
Why?
| | Aged, 80 and over | 4 | 2020 | 8333 | 0.060 |
Why?
| | Evidence-Based Medicine | 2 | 2020 | 740 | 0.060 |
Why?
| | Inflammation | 1 | 2017 | 2878 | 0.060 |
Why?
| | Immunosuppressive Agents | 2 | 2020 | 838 | 0.060 |
Why?
| | Chilblains | 1 | 2024 | 3 | 0.050 |
Why?
| | Skin Diseases, Viral | 1 | 2024 | 6 | 0.050 |
Why?
| | Skin Diseases, Vascular | 1 | 2024 | 8 | 0.050 |
Why?
| | RNA Virus Infections | 1 | 2024 | 19 | 0.050 |
Why?
| | Exanthema | 1 | 2024 | 86 | 0.050 |
Why?
| | Physicians, Women | 1 | 2024 | 89 | 0.050 |
Why?
| | Phototherapy | 1 | 2023 | 49 | 0.050 |
Why?
| | RNA Viruses | 1 | 2024 | 73 | 0.050 |
Why?
| | Lip | 1 | 2022 | 23 | 0.050 |
Why?
| | Lasers | 1 | 2023 | 126 | 0.050 |
Why?
| | Consumer Behavior | 1 | 2022 | 69 | 0.040 |
Why?
| | Skin Cream | 1 | 2021 | 11 | 0.040 |
Why?
| | Scalp | 1 | 2021 | 38 | 0.040 |
Why?
| | Hydroquinones | 1 | 2021 | 22 | 0.040 |
Why?
| | Prescriptions | 1 | 2021 | 74 | 0.040 |
Why?
| | Lasers, Dye | 1 | 2020 | 2 | 0.040 |
Why?
| | Global Burden of Disease | 1 | 2020 | 24 | 0.040 |
Why?
| | Sexism | 1 | 2021 | 68 | 0.040 |
Why?
| | Boston | 1 | 2020 | 93 | 0.040 |
Why?
| | Lasers, Solid-State | 1 | 2020 | 22 | 0.040 |
Why?
| | Psychology, Social | 1 | 2019 | 12 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 259 | 0.040 |
Why?
| | Needles | 1 | 2020 | 63 | 0.040 |
Why?
| | Administration, Cutaneous | 1 | 2019 | 127 | 0.040 |
Why?
| | Child | 1 | 2019 | 22707 | 0.040 |
Why?
| | Melanocytes | 1 | 2019 | 65 | 0.040 |
Why?
| | Standard of Care | 1 | 2019 | 81 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2018 | 20 | 0.030 |
Why?
| | History, 21st Century | 1 | 2019 | 222 | 0.030 |
Why?
| | Surgery, Plastic | 1 | 2019 | 53 | 0.030 |
Why?
| | Social Class | 1 | 2020 | 264 | 0.030 |
Why?
| | Mast Cells | 1 | 2019 | 147 | 0.030 |
Why?
| | Educational Status | 1 | 2020 | 466 | 0.030 |
Why?
| | Color | 1 | 2018 | 81 | 0.030 |
Why?
| | Minority Groups | 1 | 2019 | 284 | 0.030 |
Why?
| | Life Style | 1 | 2020 | 485 | 0.030 |
Why?
| | Editorial Policies | 1 | 2018 | 45 | 0.030 |
Why?
| | Massachusetts | 1 | 2018 | 180 | 0.030 |
Why?
| | Emigrants and Immigrants | 1 | 2020 | 157 | 0.030 |
Why?
| | Infant, Premature | 1 | 2021 | 619 | 0.030 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 561 | 0.030 |
Why?
| | Cosmetics | 1 | 2018 | 76 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1707 | 0.030 |
Why?
| | Transgender Persons | 1 | 2019 | 210 | 0.030 |
Why?
| | Seasons | 1 | 2018 | 538 | 0.030 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2020 | 641 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2019 | 547 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2018 | 2062 | 0.020 |
Why?
| | Pilot Projects | 1 | 2019 | 1891 | 0.020 |
Why?
| | Communication | 1 | 2019 | 975 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3413 | 0.020 |
Why?
| | Smoking | 1 | 2020 | 1472 | 0.020 |
Why?
| | United States | 2 | 2020 | 16098 | 0.020 |
Why?
| | Quality Improvement | 1 | 2019 | 1295 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2019 | 17291 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6447 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4316 | 0.020 |
Why?
| | Exercise | 1 | 2020 | 2198 | 0.020 |
Why?
|
|
Maymone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|